Martin Weltman

11.5k total citations · 5 hit papers
96 papers, 6.6k citations indexed

About

Martin Weltman is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Martin Weltman has authored 96 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Epidemiology, 59 papers in Hepatology and 17 papers in Surgery. Recurrent topics in Martin Weltman's work include Liver Disease Diagnosis and Treatment (48 papers), Hepatitis C virus research (45 papers) and Hepatitis B Virus Studies (26 papers). Martin Weltman is often cited by papers focused on Liver Disease Diagnosis and Treatment (48 papers), Hepatitis C virus research (45 papers) and Hepatitis B Virus Studies (26 papers). Martin Weltman collaborates with scholars based in Australia, United States and United Kingdom. Martin Weltman's co-authors include Christopher Liddle, Geoffrey C. Farrell, Jacob George, Rita Lin, Dev Samarasinghe, Gregory J. Dore, Elizabeth E. Powell, Magnus Ingelman‐Sundberg, Pauline de la Μ. Hall and Shehan Abeygunasekera and has published in prestigious journals such as Nature Communications, Nature Genetics and Gastroenterology.

In The Last Decade

Martin Weltman

91 papers receiving 6.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

2009 1.5k citations Vijayaprakash Suppiah, Golo Ahlenstiel et al. profile →
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

2002 936 citations Geoffrey C. Farrell, Rita Lin et al. Hepatology profile →
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis

1998 503 citations Martin Weltman, Geoffrey C. Farrell et al. Hepatology profile →
The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study

2012 426 citations Natasha A. Koloski, Michael Jones et al. Gut profile →
Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma

2021 331 citations Martin Weltman, Geoffrey W. McCaughan et al. Nature Communications profile →

Peers

Countries citing papers authored by Martin Weltman

Since Specialization

Citations

This map shows the geographic impact of Martin Weltman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Weltman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Weltman more than expected).

Fields of papers citing papers by Martin Weltman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Weltman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Weltman. The network helps show where Martin Weltman may publish in the future.

Co-authorship network of co-authors of Martin Weltman

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Weltman. A scholar is included among the top collaborators of Martin Weltman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Weltman. Martin Weltman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care 2023 ·Journal of Gastroenterology and Hepatology ·Paul J. Clark, Patricia C. Valery, Simone I. Strasser, Martin Weltman, (unknown), Miriam Levy, Barbara Leggett, Amany Zekry, (unknown), Marie Sinclair, Jacob George, Steven Bollipo, (unknown), William Sievert, Gerry MacQuillan, Edmund Tse, Amanda Nicoll, Amanda Wade, Wendy Cheng, Stuart K. Roberts	2
2	Loss of metabolic adaptation in lean MAFLD is driven by endotoxemia leading to epigenetic reprogramming 2023 ·Metabolism ·(unknown), Ziyan Pan, Brian Gloss, Duncan McLeod, Martin Weltman, Jacob George, Mohammed Eslam	23
3	A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes 2022 ·Nature Communications ·(unknown), Ali Bayoumi, Khaled Thabet, Ziyan Pan, Brian Gloss, Olivier Latchoumanin, Mischa Lundberg, Natalie A. Twine, Duncan McLeod, (unknown), Leon A. Adams, Martin Weltman, Thomas Berg, Christopher Liddle, Jacob George, Mohammed Eslam	29
4	A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis 2022 ·Journal of Hepatology ·Lung‐Yi Mak, Ed Gane, Christian Schwabe, Ki Tae Yoon, Jeong Heo, Russell Scott, Jeong‐Hoon Lee, Jung Il Lee, Young Oh Kweon, Martin Weltman, Stephen A. Harrison, Brent A. Neuschwander‐Tetri, Kenneth Cusi, Rohit Loomba, Bruce D. Given, Dawn R. Christianson, (unknown), Min Yi, James Hamilton, Man‐Fung Yuen	52
5	IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection 2016 ·Genes and Immunity ·K. O'Connor, Scott Read, (unknown), Stephen D. Schibeci, Mohammed Eslam, (unknown), Martin Weltman, Mark W. Douglas, Alessandra Mazzola, Antonio Craxı̀, Salvatore Petta, Graeme J. Stewart, Christopher Liddle, Jacob George, Golo Ahlenstiel, David Booth	13
6	Australian Liver Association (ALA) expert consensus recommendations for the use of transient elastography in chronic viral hepatitis 2014 ·Journal of Gastroenterology and Hepatology ·William Kemp, Miriam Levy, Martin Weltman, John Lubel	23
7	Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients: pooled analysis from 5 randomized studies 2012 ·Expert Opinion on Drug Safety ·Patrick Marcellin, Stuart K. Roberts, K. Rajender Reddy, Stephen A. Harrison, Donald M. Jensen, Stephanos J. Hadziyannis, M. Diago, Martin Weltman, Diethelm Messinger, Fernando Tatsch, Mario Rizzetto	3
8	The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study breakdown → 2012 ·Gut ·Natasha A. Koloski, Michael Jones, Jamshid S. Kalantar, Martin Weltman, (unknown), Nicholas J. Talley	426
9	Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort 2011 ·Genome Medicine ·Katherine R. Smith, Vijayaprakash Suppiah, Kate O'Connor, Thomas Berg, Martin Weltman, Maria Lorena Abate, Ulrich Spengler, Margaret F. Bassendine, Gail Matthews, William L. Irving, Elizabeth E. Powell, Stephen M. Riordan, Golo Ahlenstiel, Graeme J. Stewart, Melanie Bahlo, Jacob George, David Booth	56
10	Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy 2010 ·Addiction ·Joseph Sasadeusz, Gregory J. Dore, Ian Kronborg, Dávid Barton, (unknown), Martin Weltman	26
11	SIGNIFICANT HEMOGLOBIN (HB) DECLINE DURING PEGYLATED INTERFERON AND RIBAVIRIN THERAPY IN HCV GENOTYPE 1 IS ASSOCIATED WITH SUSTAINED VIROLOGIC RESPONSE (SVR): AN ANALYSIS FROM THE CHARIOT STUDY 2009 ·Hepatology ·William Sievert, G.J. Dore, Geoffrey W. McCaughan, (unknown), (unknown), Wenli Cheng, Martin Weltman, William D. Rawlinson, Bishoy Rizkalla, (unknown), S. Roberts	1
12	Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol? 2008 ·Addiction ·Kylie Richardson, Andrew Baillie, Sophie Reid, Kirsten C. Morley, Maree Teesson, Claudia Sannibale, Martin Weltman, Paul Haber	61
13	Progressive Fibrosis in Nonalcoholic Steatohepatitis: Association With Altered Regeneration and a Ductular Reaction 2007 ·Gastroenterology ·Michelle M. Richardson, Julie R. Jonsson, Elizabeth E. Powell, Elizabeth M. Brunt, Brent A. Neuschwander‐Tetri, Prithi S. Bhathal, John B. Dixon, Martin Weltman, Herbert Tilg, Alexander R. Moschen, David M. Purdie, Anthony J. Demetris, Andrew D. Clouston	359
14	Oropharyngeal Scintigraphy: A Reliable Technique for the Quantitative Evaluation of Oral–Pharyngeal Swallowing 2004 ·Dysphagia ·Douglas W. Shaw, Rohan B. H. Williams, Ian J. Cook, Karen L. Wallace, Martin Weltman, Peter Collins, Erin McKay, Richard Smart, Maria E. Simula	34
15	Which patients with hepatitis C develop liver complications? 2000 ·Hepatology ·(unknown), Geoffrey C. Farrell, Karen Byth, Rita Lin, Martin Weltman, (unknown), Dev Samarasinghe, James G. Kench, (unknown), Evelyn Crewe, Chris Liddle	135
16	Risk factors for development of hepatocellular carcinoma among Australians with hepatitis C: a case‐control study 1999 ·Australian and New Zealand Journal of Medicine ·Usha Dutta, Karen Byth, James G. Kench, Md. Shahadat Hossain Khan, (unknown), Martin Weltman, Ruby C.Y. Lin, Christopher Liddle, G C Farrell	23
17	Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis breakdown → 1998 ·Hepatology ·Martin Weltman, Geoffrey C. Farrell, Pauline de la Μ. Hall, Magnus Ingelman‐Sundberg, Christopher Liddle	503
18	Halothane‐induced liver injury in guinea‐pigs: Importance of cytochrome P450 enzyme activity and hepatic blood flow 1996 ·Journal of Gastroenterology and Hepatology ·Geoffrey C. Farrell, Linda Frost, Michael Tapner, Jacqueline Field, Martin Weltman, (unknown)	9
19	Coinfection with hepatitis B and C or B, C and δ viruses results in severe chronic liver disease and responds poorly to terferon‐a treatment 1995 ·Journal of Viral Hepatitis ·Martin Weltman, (unknown), Evelyn Crewe, G C Farrell, (unknown), J. Grierson, Christopher Liddle	150
20	Epidemiology of hepatitis C virus infection in Australia 1993 ·Gastroenterologia Japonica ·Geoffrey C. Farrell, Martin Weltman, (unknown), Rita Lin	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact